RespiQ Information

At RespiQ, we are bringing the analytical power of a clinical lab to the point of care, and next into patients’ homes, by measuring disease biomarkers in their breath. Our proprietary cold-plasma optical spectroscopy, combined with explainable data models, measures multiple biomarkers from a single breath in minutes, at parts-per-billion sensitivity. Today, we help biopharma and clinical nutrition sponsors close critical data gaps in their trials. Alongside patient-reported symptoms, sponsors gain objective molecular data, measured more often than site visits allow, to stratify patients, track drug response and de-risk development. Our platform is built to scale: new biomarkers are added to our spectral library, not to new hardware. That opens the way from respiratory disease, starting with early warning of COPD lung attacks, to asthma, inflammation, gastrointestinal, metabolic and oncology applications. Our vision: shift healthcare from reactive crisis care to timely, personalised intervention, with breath as a routine source of health data, in the clinic and at home.